Cogent BiosciencesCOGT
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 305 institutions reported holding Cogent Biosciences Inc. (COGT) in their 13F filings, up 38 from Q4 2025. 72 opened new positions and 34 sold out. The largest holders were FMR LLC ($890.0M), BlackRock, Inc. ($617.6M) and Deerfield Management Company, L.P. ($348.1M). 7 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio), David E. Shaw (0.1% of D. E. Shaw & Co.'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cogent Biosciences Inc.
- CUSIP
- 19240Q201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 72 | $214.2M |
| Exits | 34 | $147.7M |
All 13F filers, Q4 2025 → Q1 2026: 28,915,242 shares bought and 20,772,690 shares sold, net +8,142,552 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 305 holders
| FMR LLC | 0.05% | Add +0.1% | 23,122,748 | $890.0M |
| BlackRock, Inc. | 0.01% | Add +23.7% | 16,045,014 | $617.6M |
| Deerfield Management Company, L.P. | 4.85% | No change | 9,043,903 | $348.1M |
| Vanguard Portfolio Management LLC | 0.01% | — | 7,333,333 | $282.3M |
| Vanguard Capital Management LLC | 0.01% | — | 6,894,959 | $265.4M |
| Janus Henderson Group PLC | 0.11% | Add +31.5% | 5,965,125 | $229.6M |
| State Street Corp. | 0.01% | Add +14.6% | 5,663,543 | $218.0M |
| Fairmount Funds Management LLC | 15.30% | Reduce -38.9% | 5,503,418 | $211.8M |
| RTW Investments, LP | 2.09% | Reduce -28.1% | 5,458,675 | $210.1M |
| TCG Crossover Management, LLC | 5.45% | Reduce -15.7% | 4,946,894 | $190.4M |
| Goldman Sachs Group Inc. | 0.02% | Add +160.0% | 4,434,054 | $170.7M |
| Kynam Capital Management, LP | 9.86% | Reduce -34.5% | 4,037,331 | $155.4M |
| Geode Capital Management, LLC | 0.01% | Add +5.3% | 3,699,519 | $142.4M |
| Wellington Management Group LLP | 0.03% | Add +31.9% | 3,578,622 | $137.7M |
| T. Rowe Price Associates Inc. | 0.01% | Add +25.3% | 3,212,815 | $123.7M |
| Lord, Abbett & Co. LLC | 0.42% | Add +70.1% | 3,181,270 | $122.4M |
| Commodore Capital LP | 6.43% | Add +31.5% | 2,888,007 | $111.2M |
| Invesco Ltd. | 0.01% | Add +314.8% | 2,429,629 | $93.5M |
| Octagon Capital Advisors LP | 10.01% | No change | 2,350,000 | $90.5M |
| Holocene Advisors, LP | 0.21% | Add +91.0% | 2,250,196 | $86.6M |
| Sofinnova Investments, Inc. | 4.08% | Add +7.1% | 2,113,551 | $81.4M |
| Venrock Adviser, LLC | 2.87% | No change | 2,000,000 | $77.0M |
| D. E. Shaw & Co. | 0.06% | Reduce -16.9% | 1,868,389 | $71.9M |
| Pictet Asset Management Holding SA | 0.07% | Add +1499.3% | 1,798,768 | $68.8M |
| Citadel Advisors | 0.05% | Add +19.2% | 1,714,927 | $66.0M |
| Siren, L.L.C. | 1.82% | Add +4.9% | 1,709,279 | $65.8M |
| Marshall Wace, LLP | 0.07% | Reduce -3.6% | 1,600,168 | $61.6M |
| Emerald Advisers, LLC | 1.93% | Add +0.3% | 1,588,132 | $61.1M |
| Candriam S.C.A. | 0.30% | Add +17.0% | 1,516,297 | $58.4M |
| Woodline Partners LP | 0.22% | Add +84.4% | 1,509,557 | $58.1M |
| Point72 Asset Management | 0.10% | Add +70.5% | 1,410,826 | $54.3M |
| Silverarc Capital Management, LLC | 5.96% | Add +5.5% | 1,314,189 | $50.6M |
| Northern Trust Corp. | 0.01% | Add +3.9% | 1,245,751 | $47.9M |
| Charles Schwab Investment Management Inc. | 0.01% | Reduce -3.0% | 1,242,322 | $47.8M |
| Fred Alger Management, LLC | 0.21% | Add +12.5% | 1,239,700 | $47.7M |
| Vestal Point Capital, LP | 1.32% | New | 1,230,888 | $47.4M |
| Millennium Management | 0.04% | Reduce -1.3% | 1,192,406 | $45.9M |
| Elmind Capital, LP | 12.79% | No change | 1,170,740 | $45.1M |
| Vanguard Fiduciary Trust Co. | 0.01% | — | 1,058,087 | $40.7M |
| Bank of America Corp. | 0.00% | Reduce -12.4% | 1,043,805 | $40.2M |
| Emerald Mutual Fund Advisers Trust | 1.92% | Reduce -0.9% | 1,028,832 | $39.6M |
| Deep Track Capital, LP | 0.79% | Add +120.7% | 1,000,000 | $38.5M |
| First Turn Management, LLC | 4.07% | Add +14.9% | 947,339 | $36.5M |
| American Century Companies Inc. | 0.02% | Reduce -0.3% | 890,568 | $34.3M |
| Balyasny Asset Management L.P. | 0.07% | Reduce -40.5% | 856,598 | $33.0M |
| Nuveen, LLC | 0.01% | Reduce -10.8% | 831,602 | $32.0M |
| Squadron Capital Management LLC | 12.13% | Add +1.0% | 787,492 | $30.3M |
| J. Goldman & Co LP | 1.39% | Add +77.5% | 779,570 | $30.0M |
| Affinity Asset Advisors, LLC | 1.73% | Add +114.3% | 750,000 | $28.9M |
| Renaissance Technologies | 0.04% | Add +2.5% | 706,268 | $27.2M |
| Redmile Group, LLC | 1.75% | Reduce -52.1% | 688,036 | $26.5M |
| Burkehill Global Management, LP | 1.36% | Add +107.7% | 675,000 | $26.0M |
| Voya Investment Management LLC | 0.03% | Add +398.6% | 664,146 | $25.6M |
| Morgan Stanley | 0.00% | Reduce -11.6% | 642,679 | $24.7M |
| Saturn V Capital Management LP | 4.37% | Reduce -48.5% | 626,635 | $24.1M |
| Rock Springs Capital Management LP | 1.42% | Reduce -26.5% | 624,155 | $24.0M |
| Patient Square Capital LP | 4.07% | Add +87.8% | 596,000 | $22.9M |
| Ensign Peak Advisors, Inc | 0.04% | Add +35.9% | 572,872 | $22.0M |
| Fiera Capital Corp | 0.07% | New | 558,252 | $21.5M |
| Massachusetts Financial Services Co. | 0.01% | New | 449,482 | $17.3M |
| Vivo Capital, LLC | 1.35% | Reduce -82.4% | 422,300 | $16.3M |
| Sphera Funds Management LTD. | 2.76% | Add +10.0% | 416,340 | $16.0M |
| Qube Research & Technologies Ltd | 0.02% | Add +42.4% | 394,000 | $15.2M |
| Russell Investments Group, Ltd. | 0.02% | Reduce -2.8% | 374,868 | $14.4M |
| Bank of New York Mellon Corp | 0.00% | Reduce -0.9% | 372,796 | $14.3M |
| ExodusPoint Capital Management, LP | 0.14% | New | 372,175 | $14.3M |
| Raymond James Financial Inc. | 0.00% | Reduce -1.6% | 369,715 | $14.2M |
| Kennedy Capital Management LLC | 0.29% | Add +2.3% | 360,490 | $13.9M |
| Nomura Asset Management International Inc. | 0.02% | Add +15.8% | 354,240 | $13.6M |
| Defilade Capital Management, L.P. | 1.91% | Reduce -38.0% | 352,590 | $13.6M |
| Integral Health Asset Management, LLC | 0.71% | New | 350,000 | $13.5M |
| Weiss Asset Management LP | 0.34% | New | 346,104 | $13.3M |
| BNP Paribas Financial Markets | 0.01% | Add +72.4% | 343,082 | $13.2M |
| Longaeva Partners L.P. | 0.62% | New | 335,000 | $12.9M |
| Hennion & Walsh Asset Management, Inc. | 0.42% | Reduce -3.4% | 326,472 | $12.6M |
| Diadema Partners LP | 5.13% | Add +144.8% | 322,764 | $12.4M |
| Orbimed Advisors LLC | 0.28% | Reduce -13.2% | 322,100 | $12.4M |
| Assenagon Asset Management S.A. | 0.02% | Reduce -21.3% | 295,650 | $11.4M |
| SummitTX Capital, L.P. | 0.36% | Add +14.2% | 293,780 | $11.3M |
| Atika Capital Management LLC | 1.78% | Reduce -42.1% | 293,200 | $11.3M |
| UBS Group AG | 0.00% | Add +10.4% | 291,486 | $11.2M |
| Federated Hermes, Inc. | 0.02% | Reduce -33.1% | 285,661 | $11.0M |
| Exome Asset Management LLC | 6.31% | Reduce -8.8% | 278,533 | $10.7M |
| Aberdeen Group plc | 0.02% | New | 272,707 | $10.5M |
| Ameriprise Financial Inc. | 0.00% | Add +33.9% | 252,114 | $9.7M |
| Nantahala Capital Management, LLC | 0.60% | No change | 250,000 | $9.6M |
| Evergreen Quality Fund GP, Ltd. | 0.22% | No change | 250,000 | $9.6M |
| Alyeska Investment Group, L.P. | 0.03% | Reduce -49.4% | 250,000 | $9.6M |
| Nwi Management LP | 0.57% | No change | 241,671 | $9.3M |
| JPMorgan Chase & Co. | 0.00% | Reduce -34.5% | 262,704 | $9.3M |
| Tidal Investments LLC | 0.03% | New | 231,569 | $8.9M |
| Susquehanna Portfolio Strategies, LLC | 0.13% | No change | 229,755 | $8.8M |
| Squarepoint Ops LLC | 0.02% | Add +45.0% | 226,259 | $8.7M |
| F/m Investments LLC | 0.58% | Reduce -4.1% | 226,142 | $8.7M |
| Superstring Capital Management LP | 6.19% | Reduce -38.5% | 225,158 | $8.7M |
| Boxer Capital Management, LLC | 1.14% | No change | 225,000 | $8.7M |
| New York State Common Retirement Fund | 0.01% | Add +402.7% | 223,216 | $8.6M |
| Hudson Bay Capital Management LP | 0.05% | New | 207,574 | $8.0M |
| Peregrine Capital Management LLC | 0.29% | New | 201,959 | $7.8M |
| Cormorant Asset Management, LP | 0.39% | Reduce -11.1% | 200,000 | $7.7M |
"% of holder's portfolio" is COGT's weight in each manager's 13F, not the share of Cogent Biosciences Inc. the manager owns.